Search
for
Sort by
Research 301–330 of 1000+
- Naturally Occurring Hair Growth Peptide: Water-Soluble Chicken Egg Yolk Peptides Stimulate Hair Growth Through Induction of Vascular Endothelial Growth Factor Production
- Autologous Concentrated Growth Factors Combined with Topical Minoxidil for the Treatment of Male Androgenetic Alopecia: A Randomized Controlled Clinical Trial
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Management of androgenetic alopecia
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- Local synthesis and function of neuro-estrogen and neuro-androgen: impact on the hippocampus-related cognition and neuronal plasticity
- Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Comparative gene expression analysis of nestin-expressing hair follicle-derived cells
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Techniques d'épargne cutanée dans la chirurgie de la gynécomastie
- Comparative Study That Evaluates the Effectiveness of Intradermotherapy with 0.5% Minoxidil Versus Topical Application of 5% Monoxidil Solution in the Treatment of Androgenetic Alopecia
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- The pathogenesis of alopecia areata
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Acne
- The Skin and Subcutaneous Tissues
- Women with clinically significant hirsutism always have detectable endocrinological abnormalities
- Women with clinically significant hirsutism always have detectable endocrinological abnormalities
- Long-term physiological trends and their drivers: linking hair hormone concentrations with telemetry data in GPS-collared Serengeti wildebeest
- Hormone replacement therapy and the skin
- Estrogens and the skin
- The blastema and epimorphic regeneration in mammals
- Oral Manifestations of Hematologic and Nutritional Diseases
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome